Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy

Acta Anaesthesiologica Scandinavica

Volumn 55, Issue 1, 2011, Pages 39-45

  Broman, M ^a   Carlsson, O ^b   Friberg, H ^a   Wieslander, A ^b   Godaly, G ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Gambro AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CALCIUM ION; DIALYSIS FLUID; HEMOSOL BO; PHOSPHATE; PHOXILIUM; POTASSIUM; PROSTACYCLIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; DIALYSIS; FEMALE; HEMODIAFILTRATION; HOSPITAL ADMISSION; HUMAN; HYPOPHOSPHATEMIA; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIQUID; MAGNESIUM BLOOD LEVEL; MALE; PH; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DIALYSIS SOLUTIONS; FEMALE; HUMANS; HYPOPHOSPHATEMIA; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PHOSPHATES; RENAL REPLACEMENT THERAPY; ULTRAFILTRATION; WATER-ELECTROLYTE BALANCE;

EID: 78650000837     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2010.02338.x     Document Type: Article

References (36)

1. Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M., Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med 2004; 30: 1662-5. (Pubitemid 39094971)
2. Marik PE, Bedigian MK., Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study. Arch Surg 1996; 131: 1043-7.
3. Bugg NC, Jones JA., Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia 1998; 53: 895-902.
4. Skulberg A Sr., Glucose: a potential killer. Acta Anaesthesiol Scand 2009; 53: 684.
5. Peppers MP, Geheb M, Desai T., Endocrine crises. Hypophosphatemia and hyperphosphatemia. Crit Care Clin 1991; 7: 201-14.
6. Elisaf MS, Siamopoulos KC., Mechanisms of hypophosphataemia in alcoholic patients. Int J Clin Pract 1997; 51: 501-3.
7. Zazzo JF, Troche G, Ruel P, Maintenant J., High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function. Intensive Care Med 1995; 21: 826-31.
8. Tan HK, Bellomo R, M'Pis DA, Ronco C., Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration. Int J Artif Organs 2001; 24: 186-91.
9. Baldwin I, Naka T, Koch B, Fealy N, Bellomo R., A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance. Intensive Care Med 2007; 33: 830-5.
10. Shor R, Halabe A, Rishver S, Tilis Y, Matas Z, Fux A, Boaz M, Weinstein J., Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci 2006; 36: 67-72.
11. Stoff JS., Phosphate homeostasis and hypophosphatemia. Am J Med 1982; 72: 489-95.
12. Brown GR, Greenwood JK., Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill. Ann Pharmacother 1994; 28: 626-32.
13. Bollaert PE, Levy B, Nace L, Laterre PF, Larcan A., Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock. Chest 1995; 107: 1698-701.
14. Paterson CR., Hypophosphataemia: a dangerous disorder. Nutrition 1996; 12: 540-1.
15. Paula FJ, Plens AE, Foss MC., Effects of hypophosphatemia on glucose tolerance and insulin secretion. Horm Metab Res 1998; 30: 281-4.
16. Ravenscroft AJ, Valentine JM, Knappett PA., Severe hypophosphataemia and insulin resistance in diabetic ketoacidosis. Anaesthesia 1999; 54: 198.
17. Weber U, Huppe T, Niehaus L., CT and MRI in severe hypophosphataemia with central nervous system involvement. Neuroradiology 2000; 42: 112-4.
18. Darsee JR, Nutter DO., Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia. Ann Intern Med 1978; 89: 867-70.
19. Aubier M, Murciano D, Lecocguic Y, Viires N, Jacquens Y, Squara P, Pariente R., Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 1985; 313: 420-4. (Pubitemid 15014037)
20. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J., The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004; 66: 408-18.
21. Gatchalian RA, Popli A, Ejaz AA, Leehey DJ, Kjellstrand CM, Ing TS., Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate. Am J Kidney Dis 2000; 36: 1262-6.
22. Santiago MJ, Lopez-Herce J, Urbano J, Bellon JM, Del Castillo J, Carrillo A., Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int 2009; 75: 312-6.
23. Janssen van Doorn K, Spapen H, Geers C, Diltoer M, Shabana W., Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment? Acta Anaesthesiol Scand 2008; 52: 1259-64.
24. Lentz RD, Brown DM, Kjellstrand CM., Treatment of severe hypophosphatemia. Ann Intern Med 1978; 89: 941-4.
25. Vannatta JB, Whang R, Papper S., Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient. Arch Intern Med 1981; 141: 885-7.
26. Vannatta JB, Andress DL, Whang R, Papper S., High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia. South Med J 1983; 76: 1424-6.
27. Kingston M, Al-Siba'i MB., Treatment of severe hypophosphatemia. Crit Care Med 1985; 13: 16-8.
28. Sacks GS, Walker J, Dickerson RN, Kudsk KA, Brown RO., Observations of hypophosphatemia and its management in nutrition support. Nutr Clin Pract 1994; 9: 105-8.
29. Clark CL, Sacks GS, Dickerson RN, Kudsk KA, Brown RO., Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial. Crit Care Med 1995; 23: 1504-11.
30. Rosen GH, Boullata JI, O'Rangers EA, Enow NB, Shin B., Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia. Crit Care Med 1995; 23: 1204-10.
31. Perreault MM, Ostrop NJ, Tierney MG., Efficacy and safety of intravenous phosphate replacement in critically ill patients. Ann Pharmacother 1997; 31: 683-8.
32. Charron T, Bernard F, Skrobik Y, Simoneau N, Gagnon N, Leblanc M., Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia. Intensive Care Med 2003; 29: 1273-8.
33. Barak V, Schwartz A, Kalickman I, Nisman B, Gurman G, Shoenfeld Y., Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. Am J Med 1998; 104: 40-7.
34. Walker K, Dallas Hall W, Hurst W., Serum inorganic phosphate. In:, Stoneham M, ed. Clinical methods. London: Butterworth Publishers, 1990: 895-9.
35. Morimatsu H, Uchino S, Bellomo R, Ronco C., Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations. Int J Artif Organs 2002; 25: 512-9.
36. Kraus MA., Selection of dialysate and replacement fluids and management of electrolyte and acid-base disturbances. Semin Dial 2009; 22: 137-40.